A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in a resected pancreaticobiliary carcinoma

ConclusionsThis combination of gemcitabine and docetaxel with chemoradiation is feasible and tolerable in the adjuvant setting. Future studies utilizing a different gemcitabine/taxane combination and schedule may be appropriate in the adjuvant treatment of both pancreatic cancer and biliary tumours.

Source: HPB: official journal of the International Hepato Pancreat Biliary Association - March 20, 2015 Category: Gastroenterology Authors: May Cho, Andrea Wang‐Gillam, Robert Myerson, Feng Gao, Steven Strasberg, Joel Picus, Steven Sorscher, Chloe Fournier, Gayathri Nagaraj, Parag Parikh, Rama Suresh, David Linehan, Benjamin R. Tan Tags: Original Article Source Type: research